Estrogen actions in the cardiovascular system

Climacteric

Volumn 12, Issue SUPPL. 1, 2009, Pages 18-21

  Mendelsohn, M E ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CARDIOVASCULAR SYSTEM; ESTROGEN; Estrogen Receptors; Vascular Endothelium; Vascular Smooth Muscle

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN; ESTROGEN RECEPTOR; NITRIC OXIDE;

BIOLOGICAL MODEL; BLOOD VESSEL; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; ESTROGEN ACTIVITY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; DRUG EFFECT; ESTROGEN THERAPY; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; ENDOTHELIUM, VASCULAR; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; HUMANS; MICE; MICE, KNOCKOUT; NITRIC OXIDE; RECEPTORS, ESTROGEN;

EID: 73949152625     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130903020291     Document Type: Review

References (18)

1. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol 1994;9:619-26 (Pubitemid 24267789)
2. Mendelsohn ME, Karas RH. Mechanisms of disease: the protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11 (Pubitemid 29266405)
3. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583-7 (Pubitemid 40807497)
4. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37
5. Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 2007;14:373-84
6. Writing Group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:221-32
7. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34 (Pubitemid 36951364)
8. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004;291:1701-12
9. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease. Arch Intern Med 2006;166:356-7
10. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77 (Pubitemid 46556472)
11. Manson J, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary artery-calcification. N Engl J Med 2007;356:2591-602
12. Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med 2007;356:2639-41 (Pubitemid 46964429)
13. Vitale C, Mercuro G, Cerquetani E, et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2008;28:348-52 (Pubitemid 351161210)
14. Iafrati MD, Karas RH, Aronovitz M, et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 1997;3:545-8 (Pubitemid 27198653)
15. Karas RH, Hodgin JB, Kwoun M, et al. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci USA 1999;96:15133-6 (Pubitemid 30019777)
16. Karas RH, Schulten H, Pare G, et al. Effects of estrogen on the vascular injury response in estrogen receptor a, b (double) knockout mice. Circ Res 2001;89:534-9 (Pubitemid 34133991)
17. Pare G, Krust A, Karas RH, et al. Estrogen receptor a mediates the protective effects of estrogen against vascular injury. Circ Res 2002;90:1087-92 (Pubitemid 34627907)
18. Zhu Y, Bian Z, Lu P, et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor b. Science 2002;295:505-8 (Pubitemid 34101642)